메뉴 건너뛰기




Volumn 6, Issue 11, 2007, Pages 2976-2984

Synergistic activity of the histone deacetylase inhibitor suberoylanilide hydroxamic acid and the bisphosphonate zoledronic acid against prostate cancer cells in vitro

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; COMPACTIN; DNA FRAGMENT; FARNESOL; GERANYLGERANIOL; GGTI 298; HISTONE DEACETYLASE INHIBITOR; MEVALONIC ACID; N (2 AMINOPHENYL) 4 (3 PYRIDINYLMETHOXYCARBONYLAMINOMETHYL)BENZAMIDE; N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE METHYL ESTER; VORINOSTAT; ZOLEDRONIC ACID;

EID: 36749055778     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-07-0221     Document Type: Article
Times cited : (28)

References (45)
  • 1
    • 7244239275 scopus 로고    scopus 로고
    • Skeletal complications in men with prostate cancer: Effects on quality-of-life outcomes throughout the continuum of care
    • Crawford ED. Skeletal complications in men with prostate cancer: effects on quality-of-life outcomes throughout the continuum of care. Eur Urol 2004;3:10-5.
    • (2004) Eur Urol , vol.3 , pp. 10-15
    • Crawford, E.D.1
  • 2
    • 33644666787 scopus 로고    scopus 로고
    • Bisphosphonates for treatment and prevention of bone metastases
    • Michaelson MD, Smith MR. Bisphosphonates for treatment and prevention of bone metastases. J Clin Oncol 2005;23:8219-24.
    • (2005) J Clin Oncol , vol.23 , pp. 8219-8224
    • Michaelson, M.D.1    Smith, M.R.2
  • 3
    • 33646444443 scopus 로고    scopus 로고
    • Bisphosphonates for malignancy-related bone disease: Current status, future developments
    • Body JJ. Bisphosphonates for malignancy-related bone disease: current status, future developments. Support Care Cancer 2006;14:408-18.
    • (2006) Support Care Cancer , vol.14 , pp. 408-418
    • Body, J.J.1
  • 4
    • 0037009822 scopus 로고    scopus 로고
    • A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
    • Saad F, Gleason DM, Murray R, et al. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst 2002;94:1458-68.
    • (2002) J Natl Cancer Inst , vol.94 , pp. 1458-1468
    • Saad, F.1    Gleason, D.M.2    Murray, R.3
  • 5
    • 2942518111 scopus 로고    scopus 로고
    • Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer
    • Saad F, Gleason DM, Murray R, et al. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 2004;96:879-82.
    • (2004) J Natl Cancer Inst , vol.96 , pp. 879-882
    • Saad, F.1    Gleason, D.M.2    Murray, R.3
  • 7
    • 0036901126 scopus 로고    scopus 로고
    • Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis
    • Green JR, Cleza rdin P. Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis. Am J Clin Oncol 2002;25:S3-9.
    • (2002) Am J Clin Oncol , vol.25
    • Green, J.R.1    Cleza rdin, P.2
  • 8
    • 33750733277 scopus 로고    scopus 로고
    • Molecular mechanisms of action of bisphosphonates: Current status
    • s
    • Roelofs AJ, Thompson K, Gordon S, Rogers MJ. Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res 2006;12:6222-30s.
    • (2006) Clin Cancer Res , vol.12 , pp. 6222-6230
    • Roelofs, A.J.1    Thompson, K.2    Gordon, S.3    Rogers, M.J.4
  • 9
    • 0029898894 scopus 로고    scopus 로고
    • Protein prenylation: Molecular mechanisms and functional consequences
    • Zhang FL, Casey PJ. Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 1996;65:241-69.
    • (1996) Annu Rev Biochem , vol.65 , pp. 241-269
    • Zhang, F.L.1    Casey, P.J.2
  • 10
    • 5444242637 scopus 로고    scopus 로고
    • Bisphosphonates: Preclinical review
    • Green JR. Bisphosphonates: preclinical review. Oncologist 2004;9 Suppl 4:3-13.
    • (2004) Oncologist , vol.9 , Issue.SUPPL. 4 , pp. 3-13
    • Green, J.R.1
  • 11
    • 20444486612 scopus 로고    scopus 로고
    • Bisphosphonates and cancer-induced bone disease: Beyond their antiresorptive activity
    • Clezardin P, Ebetino FH, Fournier PG. Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity. Cancer Res 2005;65:4971-4.
    • (2005) Cancer Res , vol.65 , pp. 4971-4974
    • Clezardin, P.1    Ebetino, F.H.2    Fournier, P.G.3
  • 12
    • 28644440158 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors: Discovery and development as anticancer agents
    • Marks PA, Dokmanovic M. Histone deacetylase inhibitors: discovery and development as anticancer agents. Expert Opin Investig Drugs 2005;14:1497-511.
    • (2005) Expert Opin Investig Drugs , vol.14 , pp. 1497-1511
    • Marks, P.A.1    Dokmanovic, M.2
  • 15
    • 33846122993 scopus 로고    scopus 로고
    • Dimethyl sulfoxide to vorinostat: Development of this histone deacetylase inhibitor as an anticancer drug
    • Marks PA, Breslow R. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nat Biotechnol 2007;25:84-90.
    • (2007) Nat Biotechnol , vol.25 , pp. 84-90
    • Marks, P.A.1    Breslow, R.2
  • 16
    • 33748794547 scopus 로고    scopus 로고
    • Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
    • Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 2006;58:621-681.
    • (2006) Pharmacol Rev , vol.58 , pp. 621-681
    • Chou, T.C.1
  • 17
    • 0242432345 scopus 로고    scopus 로고
    • Many cuts to ruin: A comprehensive update of caspase substrates
    • Fischer U, Janicke RU, Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 2003;10:76-100.
    • (2003) Cell Death Differ , vol.10 , pp. 76-100
    • Fischer, U.1    Janicke, R.U.2    Schulze-Osthoff, K.3
  • 18
    • 0042090495 scopus 로고    scopus 로고
    • Novel mechanisms of apoptosis induced by histone deacetylase inhibitors
    • Peart MJ, Tainton KM, Ruefli AA, et al. Novel mechanisms of apoptosis induced by histone deacetylase inhibitors. Cancer Res 2003;63:4460-71.
    • (2003) Cancer Res , vol.63 , pp. 4460-4471
    • Peart, M.J.1    Tainton, K.M.2    Ruefli, A.A.3
  • 19
    • 33845910925 scopus 로고    scopus 로고
    • Zoledronic acid activates the DNA S-phase checkpoint and induces osteosarcoma cell death characterized by apoptosis-inducing factor and endonuclease-G translocation independently of p53 and retinoblastoma status
    • Ory B, Blanchard F, Battaglia S, Gouin F, Redini F, Heymann D. Zoledronic acid activates the DNA S-phase checkpoint and induces osteosarcoma cell death characterized by apoptosis-inducing factor and endonuclease-G translocation independently of p53 and retinoblastoma status. Mol Pharmacol 2007;71:333-43.
    • (2007) Mol Pharmacol , vol.71 , pp. 333-343
    • Ory, B.1    Blanchard, F.2    Battaglia, S.3    Gouin, F.4    Redini, F.5    Heymann, D.6
  • 20
    • 0031589542 scopus 로고    scopus 로고
    • Novel salvage pathway utilizing farnesol and geranylgeraniol for protein isoprenylation
    • Crick DC, Andres DA, Waechter CJ. Novel salvage pathway utilizing farnesol and geranylgeraniol for protein isoprenylation. Biochem Biophys Res Commun 1997;237:483-7.
    • (1997) Biochem Biophys Res Commun , vol.237 , pp. 483-487
    • Crick, D.C.1    Andres, D.A.2    Waechter, C.J.3
  • 21
    • 0028973293 scopus 로고
    • Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes
    • Lerner EC, Qian Y, Blaskovich MA, et al. Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes. J Biol Chem 1995;270:26802-6.
    • (1995) J Biol Chem , vol.270 , pp. 26802-26806
    • Lerner, E.C.1    Qian, Y.2    Blaskovich, M.A.3
  • 22
    • 0029926493 scopus 로고    scopus 로고
    • Platelet-derived growth factor receptor tyrosine phosphorylation requires protein geranylgeranylation but not farnesylation
    • McGuire TF, Qian Y, Vogt A, Hamilton AD, Sebti SM. Platelet-derived growth factor receptor tyrosine phosphorylation requires protein geranylgeranylation but not farnesylation. J Biol Chem 1996;271:27402-7.
    • (1996) J Biol Chem , vol.271 , pp. 27402-27407
    • McGuire, T.F.1    Qian, Y.2    Vogt, A.3    Hamilton, A.D.4    Sebti, S.M.5
  • 23
    • 33845944650 scopus 로고    scopus 로고
    • Multilevel modulation of the mevalonate and protein-prenylation circuitries as a novel strategy for anticancer therapy
    • Konstantinopoulos PA, Papavassiliou AG. Multilevel modulation of the mevalonate and protein-prenylation circuitries as a novel strategy for anticancer therapy. Trends Pharmacol Sci 2007;28:6-13.
    • (2007) Trends Pharmacol Sci , vol.28 , pp. 6-13
    • Konstantinopoulos, P.A.1    Papavassiliou, A.G.2
  • 25
    • 0141455522 scopus 로고    scopus 로고
    • Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis
    • Evdokiou A, Labrinidis A, Bouralexis S, Hay S, Findlay DM. Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis. Bone 2003;33:216-28.
    • (2003) Bone , vol.33 , pp. 216-228
    • Evdokiou, A.1    Labrinidis, A.2    Bouralexis, S.3    Hay, S.4    Findlay, D.M.5
  • 27
    • 0030931858 scopus 로고    scopus 로고
    • Bisphosphonates induce apoptosis in human myeloma cell lines: A novel anti-tumour activity
    • Shipman CM, Rogers MJ, Apperley JF, Russell RG, Croucher PI. Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity. Br J Haematol 1997;98:665-72.
    • (1997) Br J Haematol , vol.98 , pp. 665-672
    • Shipman, C.M.1    Rogers, M.J.2    Apperley, J.F.3    Russell, R.G.4    Croucher, P.I.5
  • 28
    • 33750367958 scopus 로고    scopus 로고
    • Antitumor effects of amino-bisphosphonates on renal cell carcinoma cell lines
    • Pandha H, Birchall L, Meyer B, et al. Antitumor effects of amino-bisphosphonates on renal cell carcinoma cell lines. J Urol 2006;176:2255-61.
    • (2006) J Urol , vol.176 , pp. 2255-2261
    • Pandha, H.1    Birchall, L.2    Meyer, B.3
  • 29
    • 10444274954 scopus 로고    scopus 로고
    • Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anticancer agents against small cell lung cancer cell lines
    • Matsumoto S, Kimura S, Segawa H, et al. Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anticancer agents against small cell lung cancer cell lines. Lung Cancer 2005;47:31-9.
    • (2005) Lung Cancer , vol.47 , pp. 31-39
    • Matsumoto, S.1    Kimura, S.2    Segawa, H.3
  • 31
    • 0033783227 scopus 로고    scopus 로고
    • Bisphosphonates induce breast cancer cell death in vitro
    • Fromigue O, Lagneaux L, Body JJ. Bisphosphonates induce breast cancer cell death in vitro. J Bone Miner Res 2000;15:2211-21.
    • (2000) J Bone Miner Res , vol.15 , pp. 2211-2221
    • Fromigue, O.1    Lagneaux, L.2    Body, J.J.3
  • 32
    • 0035866791 scopus 로고    scopus 로고
    • Bisphosphonate treatment inhibits the growth of prostate cancer cells
    • Lee MV, Fong EM, Singer FR, Guenette RS. Bisphosphonate treatment inhibits the growth of prostate cancer cells. Cancer Res 2001;61:2602-8.
    • (2001) Cancer Res , vol.61 , pp. 2602-2608
    • Lee, M.V.1    Fong, E.M.2    Singer, F.R.3    Guenette, R.S.4
  • 33
    • 0037236978 scopus 로고    scopus 로고
    • Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer
    • Corey E, Brown LG, Quinn JE, et al. Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer. Clin Cancer Res 2003;9:295-306.
    • (2003) Clin Cancer Res , vol.9 , pp. 295-306
    • Corey, E.1    Brown, L.G.2    Quinn, J.E.3
  • 34
    • 0037664952 scopus 로고    scopus 로고
    • Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells
    • Oades GM, Senaratne SG, Clarke IA, Kirby RS, Colston KW. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells. J Urol 2003;170:246-52.
    • (2003) J Urol , vol.170 , pp. 246-252
    • Oades, G.M.1    Senaratne, S.G.2    Clarke, I.A.3    Kirby, R.S.4    Colston, K.W.5
  • 35
    • 3242771333 scopus 로고    scopus 로고
    • Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation
    • Coxon JP, Oades GM, Kirby RS, Colston KW. Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation. BJU Int 2004;94:164-70.
    • (2004) BJU Int , vol.94 , pp. 164-170
    • Coxon, J.P.1    Oades, G.M.2    Kirby, R.S.3    Colston, K.W.4
  • 36
    • 0043075946 scopus 로고    scopus 로고
    • Effect of the combination of docetaxel, zoledronic acid, and a COX-2 inhibitor on the growth of human breast cancer cell lines
    • Witters LM, Crispino J, Fraterrigo T, Green J, Lipton A. Effect of the combination of docetaxel, zoledronic acid, and a COX-2 inhibitor on the growth of human breast cancer cell lines. Am J Clin Oncol 2003;26:S92-7.
    • (2003) Am J Clin Oncol , vol.26
    • Witters, L.M.1    Crispino, J.2    Fraterrigo, T.3    Green, J.4    Lipton, A.5
  • 37
    • 0141790853 scopus 로고    scopus 로고
    • The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph + leukemia activity of imatinib mesylate
    • Kuroda J, Kimura S, Segawa H, et al. The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph + leukemia activity of imatinib mesylate. Blood 2003;102:2229-35.
    • (2003) Blood , vol.102 , pp. 2229-2235
    • Kuroda, J.1    Kimura, S.2    Segawa, H.3
  • 38
    • 11144254409 scopus 로고    scopus 로고
    • Sequence- and schedule-dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cells
    • Neville-Webbe HL, Rostami-Hodjegan A, Evans CA, Coleman RE, Holen I. Sequence- and schedule-dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cells. Int J Cancer 2005;113:364-71.
    • (2005) Int J Cancer , vol.113 , pp. 364-371
    • Neville-Webbe, H.L.1    Rostami-Hodjegan, A.2    Evans, C.A.3    Coleman, R.E.4    Holen, I.5
  • 39
    • 20544442197 scopus 로고    scopus 로고
    • Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma
    • Heymann D, Ory B, Blanchard F, et al. Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma. Bone 2005;37:74-86.
    • (2005) Bone , vol.37 , pp. 74-86
    • Heymann, D.1    Ory, B.2    Blanchard, F.3
  • 40
    • 32044447160 scopus 로고    scopus 로고
    • Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment
    • Brubaker KD, Brown LG, Vessella RL, Corey E. Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment. BMC Cancer 2006;6:15.
    • (2006) BMC Cancer , vol.6 , pp. 15
    • Brubaker, K.D.1    Brown, L.G.2    Vessella, R.L.3    Corey, E.4
  • 41
    • 33846523379 scopus 로고    scopus 로고
    • Combined effects of a third-generation bisphosphonate, zoledronic acid with other anticancer agents against murine osteosarcoma
    • Horie N, Murata H, Kimura S, et al. Combined effects of a third-generation bisphosphonate, zoledronic acid with other anticancer agents against murine osteosarcoma. Br J Cancer 2007;96:255-61.
    • (2007) Br J Cancer , vol.96 , pp. 255-261
    • Horie, N.1    Murata, H.2    Kimura, S.3
  • 42
    • 34047129164 scopus 로고    scopus 로고
    • Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells
    • Benassi MS, Chiechi A, Ponticelli F, et al. Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells. Cancer Lett 2007;250:194-205.
    • (2007) Cancer Lett , vol.250 , pp. 194-205
    • Benassi, M.S.1    Chiechi, A.2    Ponticelli, F.3
  • 43
    • 0037169358 scopus 로고    scopus 로고
    • Apoptosis: A link between cancer genetics and chemotherapy
    • Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002;108:153-64.
    • (2002) Cell , vol.108 , pp. 153-164
    • Johnstone, R.W.1    Ruefli, A.A.2    Lowe, S.W.3
  • 44
    • 33645638181 scopus 로고    scopus 로고
    • Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells
    • Goffinet M, Thoulouzan M, Pradines A, et al. Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells. BMC Cancer 2006;6:60.
    • (2006) BMC Cancer , vol.6 , pp. 60
    • Goffinet, M.1    Thoulouzan, M.2    Pradines, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.